NEW YORK, NY / ACCESSWIRE / March 18, 2021 / Ezra, the NY-based startup transforming early cancer screening using MRI, announced today it has added the Ezra Prostate MRI with IV Contrast to its suite ...

An MRI with contrast uses a special dye to make blood vessels, organs, and tissues stand out more clearly. The dye used in MRI with contrast contains gadolinium and is delivered through an IV, orally, ...

(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...

Dec. 5, 2003 -- Intravenous and intra-articular enhanced magnetic resonance imaging (MRI) are comparable for evaluating meniscal tears, and both are better than nonenhanced MRI, according to the ...

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that change the market dynamics of the industry. It provides an in-depth analysis of the ...

The global MRI-compatible IV infusion pump systems market is on a dynamic growth path, with projections showing a significant rise from USD 234.8 million in 2022 to USD 580.3 million by 2032. This ...

CHICAGO--(BUSINESS WIRE)--The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) today announced an educational partnership to help train sonographers to perform ...

(Nanowerk News) The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels. A team ...

CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...